Submitted by Anonymous (not verified) on 20 September 2024 - 8:54
Human medicines European public assessment report (EPAR): Ninlaro, ixazomib, Date of authorisation: 21/11/2016, Revision: 19, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Ninlaro, ixazomib, Date of authorisation: 21/11/2016, Revision: 19, Status: Authorised